What financial and other help are available to access bispecific antibody therapies?

Often, the cost of myeloma therapies (including newly released drugs like these bispecific antibodies) can be an area of overwhelm. Coverage differs depending on insurance, and often, patients and their loved ones are left with large copays and prescription bills. 

The following sections contain financial and other support resources if you are considering/currently prescribed a bispecific antibody therapy for your multiple myeloma treatment.